American Hospital Association et al. v. Xavier Becerra et al.

  1. July 07, 2023

    HHS Floats $9B Drug-Discount Fix After High Court Loss

    The Centers for Medicare & Medicaid Services on Friday proposed a $9 billion lump sum remedy for hospitals participating in a special drug-discount program after the U.S. Supreme Court last year rejected the U.S. Department of Health and Human Services agency's massive reimbursement cut.

  2. September 02, 2022

    The Hottest Topics For Health Attys In 2022's Homestretch

    A torrid 2022 for health care litigation is entering a red-hot homestretch featuring fallout from the U.S. Supreme Court's explosive repudiation of abortion rights, the potential for three False Claims Act clashes at the high court, and the increasingly likely prospect of a funding fiasco for the U.S. Food and Drug Administration.

  3. July 21, 2022

    The Rulings That Quickly Made 2022 Huge For Health Law

    A spree of remarkable rulings has already made 2022 a jaw-dropping year for health care and pharmaceutical law, where the U.S. Supreme Court reshaped abortion rights, opioid crisis prosecutions, Medicare's rulemaking powers and vital sources of hospital income. At the midyear mark, Law360 recaps the rulings and analyzes their implications.

  4. June 16, 2022

    Chevron Deference Still Feels Heat After High Court Reprieve

    The U.S. Supreme Court's landmark doctrine requiring judicial deference to federal regulators survived a major health care case at the high court Wednesday, but the controversial bedrock of administrative law barely escaped the conservative justices' frying pan and is heading right back into their fire, experts say.

  5. June 15, 2022

    High Court Rejects Medicare's $1.6B Cut To Hospital Drug Pay

    The U.S. Supreme Court on Wednesday overturned a massive pay cut for hospitals in a controversial drug-discount program, finding that the U.S. Department of Health and Human Services improperly failed to gather crucial pricing information.

  6. January 03, 2022

    A Blockbuster Year Ahead For Health, Life Sciences Litigation

    Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.

  7. November 30, 2021

    High Court's Right Flank Floats Chevron Deference Overhaul

    Five conservative justices on the U.S. Supreme Court suggested Tuesday that a multibillion-dollar battle over Medicare drug reimbursement could become a vehicle for clarifying or nullifying so-called Chevron deference, a backbone of federal regulatory power and increasingly high-priority target of corporate America.

  8. September 20, 2021

    Justices Set Abortion Fight Oral Arguments For Dec. 1

    The U.S. Supreme Court on Monday scheduled oral arguments for late November and early December in three high-profile health care cases, including an abortion case that could result in Roe v. Wade being overturned and two appeals over federal limitations on hospital reimbursements.

  9. September 09, 2021

    Pacific Legal Backs Challenge To Drug Program Cuts

    The Pacific Legal Foundation has told the U.S. Supreme Court that it is throwing its support behind a challenge to the federal government's decision to cut billions of dollars from reimbursements for drugs bought through a discount program for hospitals in low-income areas.

  10. July 02, 2021

    Justices Agree To Review Medicare Reimbursement Programs

    The U.S. Supreme Court on Friday agreed to review whether the federal government lawfully cut billions of dollars from reimbursements for drugs bought through a discount program for hospitals in low-income areas, as well as a reimbursement calculation for hospitals that serve a high amount of low-income individuals.